Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroendocrine Tumors × Phlebotomy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 4 Lung Neoplasms 4 Breast Neoplasms 3 Lymphoma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Sarcoma 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Dysautonomias 1 Polycythemia Vera 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Pancreatitis, Chronic 1 Pancreatitis 1 Pancreatic Cyst 1 Ovarian Neoplasms 1

Interventions

lutetium Lu 177 dotatate 28 Everolimus 17 Magnetic Resonance Spectroscopy 10 gallium Ga 68 dotatate 9 Temozolomide 9 Capecitabine 9 lanreotide 8 Nivolumab 8 Positron Emission Tomography Computed Tomography 7 177Lu-octreotide, DOTA(0)-Tyr(3)- 7 cabozantinib 6 Somatostatin 6 90Y-octreotide, DOTA-Tyr(3)- 6 3-Iodobenzylguanidine 6 pembrolizumab 5 Octreotide 5 Lutetium-177 5 Ga(III)-DOTATOC 5 Fluorodeoxyglucose F18 5 telotristat ethyl 4 avelumab 4 Carboplatin 4 Bevacizumab 4 Al18F-NOTA-octreotide 4 pasireotide 3 lenvatinib 3 fluorodopa F 18 3 copper dotatate CU-64 3 Surveys and Questionnaires 3 Single Photon Emission Computed Tomography Computed Tomography 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03130205 2017-08-25

PROGRESS

Uppsala University

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡